Treatment of Inverse Psoriasis
Topical calcineurin inhibitors (tacrolimus 0.1% or pimecrolimus 1%) are the first-line therapy for inverse psoriasis due to their efficacy and lack of skin atrophy in sensitive intertriginous areas. 1
Understanding Inverse Psoriasis
Inverse psoriasis affects intertriginous areas, including axillae, inframammary areas, abdominal folds, inguinal folds, gluteal folds, groin, genitalia, perineum, and perirectal areas. It appears as erythematous, less indurated, and well-demarcated lesions with minimal scale.
Treatment Algorithm
First-Line Treatment
- Topical calcineurin inhibitors (TCIs):
- Tacrolimus 0.1% or pimecrolimus 1% ointment
- Apply twice daily for 4-8 weeks
- Efficacy: 65-71% of patients achieve clear or almost clear status after 8 weeks 1
- Advantages: No skin atrophy, safe for long-term use in sensitive areas
- Note: Despite FDA boxed warning regarding theoretical malignancy risk, there is no evidence showing increased risk with topical use 1
Second-Line Treatment (for inadequate response after 4-8 weeks)
- Low-potency topical corticosteroids:
Alternative Topical Options
Vitamin D analogs:
Emollients:
For Widespread or Severe Disease Unresponsive to Topical Therapies
Targeted phototherapy:
- 308-nm excimer laser for resistant areas 1
Systemic therapies:
Important Considerations and Precautions
Avoid in Inverse Psoriasis
- Anthralin: Application to face and flexures should be avoided due to staining and irritation 2
- Coal tar: Can cause local irritation, folliculitis, and contact dermatitis 2
- High-potency corticosteroids: Increased risk of atrophy, striae, and systemic absorption in intertriginous areas 1
Additional Management Tips
- Rule out secondary infections, especially candidiasis, in intertriginous areas 1
- Advise patients to avoid tight clothing and reduce friction in affected areas 1
- Apply medications to dry skin to minimize irritation with calcineurin inhibitors 1
- Consider the psychological impact of genital and intertriginous psoriasis, which can significantly affect quality of life regardless of overall disease severity 1
Monitoring
- Assess treatment response after 4-8 weeks
- For patients using topical corticosteroids, monitor for signs of skin atrophy
- For patients with inadequate response to topical therapy, consider referral to dermatology for consideration of systemic therapy
By following this treatment algorithm, most patients with inverse psoriasis can achieve significant improvement in their condition while minimizing adverse effects associated with treatment.